• Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31541927).
  
• Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Glu415Ter (c.1243G>T); Zygosity=Heterozygous (PubMed=31541927).
  
• Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Arg234His (c.701G>A); ClinVar=VCV000134959; Zygosity=Heterozygous (PubMed=31541927).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Phe (c.481_482GC>TT); Zygosity=Heterozygous (PubMed=23613873; PubMed=31541927).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Tyr (c.527G>A); ClinVar=VCV000186451; Zygosity=Heterozygous (PubMed=23613873; PubMed=31541927).
  

PubMed=8824719; DOI=10.1002/(SICI)1098-2264(199601)15:1<1::AID-GCC1>3.0.CO;2-8
Hermsen M.A.J.A., Joenje H., Arwert F., Welters M.J.P., Braakhuis B.J.M., Bagnay M., Westerveld A., Slater R.M.
Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma.
Genes Chromosomes Cancer 15:1-9(1996)

PubMed=9139877; DOI=10.1002/(SICI)1097-0215(19970502)71:3<410::AID-IJC18>3.0.CO;2-J
Welters M.J.P., Fichtinger-Schepman A.M.J., Baan R.A., Hermsen M.A.J.A., van der Vijgh W.J.F., Cloos J., Braakhuis B.J.M.
Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines.
Int. J. Cancer 71:410-415(1997)

PubMed=15735012; DOI=10.1158/0008-5472.CAN-04-3665
van Zeeburg H.J.T., Snijders P.J.F., Pals G., Hermsen M.A.J.A., Rooimans M.A., Bagby G., Soulier J., Gluckman E., Wennerberg J., Leemans C.R., Joenje H., Brakenhoff R.H.
Generation and molecular characterization of head and neck squamous cell lines of Fanconi anemia patients.
Cancer Res. 65:1271-1276(2005)

PubMed=23613873; DOI=10.1371/journal.pone.0061555; PMCID=PMC3629194
Martens-de Kemp S.R., Dalm S.U., Wijnolts F.M.J., Brink A., Honeywell R.J., Peters G.J., Braakhuis B.J.M., Brakenhoff R.H.
DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cells.
PLoS ONE 8:E61555-E61555(2013)

PubMed=26122845; DOI=10.1158/0008-5472.CAN-15-0528
Stoepker C., Ameziane N., van der Lelij P., Kooi I.E., Oostra A.B., Rooimans M.A., van Mil S.E., Brink A., Dietrich R., Balk J.A., Ylstra B., Joenje H., Feller S.M., Brakenhoff R.H.
Defects in the Fanconi anemia pathway and chromatid cohesion in head and neck cancer.
Cancer Res. 75:3543-3553(2015)

PubMed=31541927; DOI=10.1016/j.oraloncology.2019.09.004; PMCID=PMC7372097
van Harten A.M., Poell J.B., Buijze M., Brink A., Wells S.I., Leemans C.R., Wolthuis R.M.F., Brakenhoff R.H.
Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass.
Oral Oncol. 98:53-61(2019)